Cullis PR, Hope MJ. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 2017;25:1467–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maeki M, Uno S, Niwa A, Okada Y, Tokeshi M. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery. J Controlled Release. 2022;344:80–96.

Article  CAS  Google Scholar 

Kulkarni JA, Witzigmann D, Leung J, van der Meel R, Zaifman J, Darjuan MM, et al. Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads. Nanoscale. 2019;11:9023–31.

Article  CAS  PubMed  Google Scholar 

Terada T, Kulkarni JA, Huynh A, Chen S, van der Meel R, Tam YYC, et al. Characterization of lipid nanoparticles containing ionizable cationic lipids using Design-of-Experiments approach. Langmuir. 2021;37:1120–8.

Article  CAS  PubMed  Google Scholar 

Hourdel L, Lebaz N, Peral F, Ripoll M, Briançon S, Bensaid F, et al. Overview on LNP-mRNA encapsulation unit operation: mixing technologies, scalability, and influence of formulation & process parameters on physico-chemical characteristics. Int J Pharm. 2025;672:125297.

Article  CAS  PubMed  Google Scholar 

Leung AKK, Tam YYC, Chen S, Hafez IM, Cullis PR. Microfluidic mixing: A general method for encapsulating macromolecules in lipid nanoparticle systems. J Phys Chem B. 2015;119:8698–706.

Article  CAS  PubMed  Google Scholar 

Bi D, Wilhelmy C, Unthan D, Keil IS, Zhao B, Kolb B, et al. On the influence of fabrication methods and materials for mRNA-LNP production: from size and morphology to internal structure and mRNA delivery performance in vitro and in vivo. Adv Healthc Mater. 2024;13:e2401252.

Article  PubMed  Google Scholar 

Vargas R, Romero M, Berasategui T, Narváez-Narváez DA, Ramirez P, Nardi-Ricart A, et al. Dialysis is a key factor modulating interactions between critical process parameters during the microfluidic Preparation of lipid nanoparticles. Colloid Interface Sci Commun. 2023;54:100709.

Article  CAS  Google Scholar 

Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int J Pharm. 2021;601:120586.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hashiba K, Taguchi M, Sakamoto S, Otsu A, Maeda Y, Ebe H, et al. Overcoming thermostability challenges in mRNA–lipid nanoparticle systems with piperidine-based ionizable lipids. Commun Biol. 2024;7:1–13.

Article  Google Scholar 

Packer M, Gyawali D, Yerabolu R, Schariter J, White P. A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems. Nat Commun. 2021;12:6777.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li M, Jia L, Xie Y, Ma W, Yan Z, Liu F, et al. Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine. NPJ Vaccines. 2023;8:153.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kulkarni JA, Thomson S, Zaifman J, Leung D, Tam YYC, Cullis PR et al. Spontaneous, solvent-free entrapment of SiRNA within lipid nanoparticles. 2020;1622–30.

Tanaka H, Hagiwara S, Shirane D, Yamakawa T, Sato Y, Matsumoto C, et al. Ready-to-Use-Type lyophilized lipid nanoparticle formulation for the postencapsulation of messenger RNA. ACS Nano. 2023;17:2588–601.

Article  CAS  PubMed  Google Scholar 

Ripoll M, Martin E, Enot M, Robbe O, Rapisarda C, Nicolai M-C, et al. Optimal self-assembly of lipid nanoparticles (LNP) in a ring micromixer. Sci Rep. 2022;12:9483.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roces CB, Lou G, Jain N, Abraham S, Thomas A, Halbert GW, et al. Manufacturing considerations for the development of lipid nanoparticles using microfluidics. Pharmaceutics. 2020;12:1095.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Liu S, Sun Y, Yu X, Lee SM, Cheng Q, et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nat Protoc. 2023;18:265–91.

Article  CAS  PubMed  Google Scholar 

Mousli Y, Brachet M, Chain JL, Ferey L. A rapid and quantitative reversed-phase HPLC-DAD/ELSD method for lipids involved in nanoparticle formulations. J Pharm Biomed Anal. 2022;220:115011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hald Albertsen C, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022;188:114416.

Article  CAS  PubMed  PubMed Central  Google Scholar 

European Medecines Agency. EPAR - Spikevax previously covid 19 vaccine Moderna. Accessed on 10. March 2025. 2021.

Alexandre L, Dubrova A, Kunduru A, Surply E, Ribes C, Boucenna I, et al. Investigating extracellular vesicles in viscous formulations: interplay of nanoparticle tracking and nanorheology via interferometric light microscopy. Small Sci. 2025;5:2400319.

Article  CAS  PubMed  Google Scholar 

Buschmann MD, Carrasco MJ, Alishetty S, Paige M, Alameh MG, Weissman D. Nanomaterial delivery systems for mRNA vaccines. Vaccines (Basel). 2021;9:65.

Article  CAS  PubMed  Google Scholar 

Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov. 2021;20:817–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakamura K, Aihara K, Ishida T. Importance of process parameters influencing the mean diameters of siRNA-Containing lipid nanoparticles (LNPs) on the in vitro activity of prepared LNPs. Biol Pharm Bull. 2022;45:497–507.

Article  CAS  PubMed  Google Scholar 

Binici B, Borah A, Watts JA, McLoughlin D, Perrie Y. The influence of citrate buffer molarity on mRNA-LNPs: exploring factors beyond general critical quality attributes. Int J Pharm. 2025;668:124942.

Article  CAS  PubMed  Google Scholar 

Cárdenas M, Campbell RA, Yanez Arteta M, Lawrence MJ, Sebastiani F. Review of structural design guiding the development of lipid nanoparticles for nucleic acid delivery. Curr Opin Colloid Interface Sci. 2023;66:101705.

Article  Google Scholar 

Simonsen JB. A perspective on bleb and empty LNP structures. J Controlled Release. 2024;373:952–61.

Article  CAS  Google Scholar 

Cheng MHY, Leung J, Zhang Y, Strong C, Basha G, Momeni A, et al. Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency. Adv Mater. 2023;35:2303370.

Article  CAS  Google Scholar 

Geng C, Zhou K, Yan Y, Li C, Ni B, Liu J, et al. A Preparation method for mRNA-LNPs with improved properties. J Controlled Release. 2023;364:632–43.

Article  CAS  Google Scholar 

Sluka KA, Kalra A, Moore SA. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve. 2001;24:37–46.

Article  CAS  PubMed  Google Scholar 

Louca Jounger S, Eriksson N, Lindskog H, Oscarsson A, Simonsson V, Ernberg M, et al. Repeated buffered acidic saline infusion in the human masseter muscle as a putative experimental pain model. Sci Rep. 2019;9:15474.

Article  PubMed  PubMed Central  Google Scholar 

Klement W, Arndt JO. Pain on I.V. Injection of some anaesthetic agents is evoked by the unphysiological osmolality or pH of their formulations. Br J Anaesth. 1991;66:189–95.

Article  CAS  PubMed  Google Scholar